ClinicalTrials.gg
RecruitingNCT06337812Updated Jul 24, 2025

Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)

An interventional study of Potato Starch in Type2diabetes and Heart Failure With Preserved Ejection Fraction, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-24.

Sponsored by University of Michigan · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Diabetes Mellitus, Type 2 by University of Michigan — 5 open to participants now, 5 under way, none of them phase 3. Diabetes Mellitus, Type 2 · University of Michigan.

Planned enrollment
27th of 36
30 · median 48
Started
2024
with 2 others
No phase
31 of 38
3 open now
Registered
36th of 38
by date

Among the 38 studies in Diabetes Mellitus, Type 2 by University of Michigan, this one is the 27th largest by planned enrollment of the 36 interventional ones that give a count, is one of 3 that started in 2024, is one of 31 with no phase, and was the 36th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

5 of the 38 studies in Diabetes Mellitus, Type 2 by University of Michigan are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Diabetes Mellitus, Type 2 by University of Michigan, or all of them as a file.
02

Study summary

The study team is studying how increasing dietary fiber, specifically through adding potato starch to participant's diet, may impact the species of bacteria in participant's gut microbiome. The study team also wants to understand if adding potato starch to participant's diet helps these bacteria make more short chain fatty acids, a byproduct the team thinks may benefit participant's health.

03

Conditions studied

  • Type2diabetes
  • Heart Failure With Preserved Ejection Fraction

Keywords

  • Fiber Supplementation
  • Potato Starch
  • Gut microbiome
  • Resistant starch
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A confirmed clinical diagnosis of stable HFpEF on maximally tolerated Heart Failure (HF) medical regimen (without changes in dosage in the prior month)
  • of >50% documented in the prior 12 months
  • A confirmed clinical diagnosis of Type II diabetes (T2DM) with \<10% without changes in medical regimen in the past month.

Exclusion criteria

Exclusion Criteria:

  • Current usage of pre- or probiotic usage
  • Antibiotic usage in the past 6 months
  • Current participation in another interventional clinical trial
  • History of potato allergy or potato starch allergy, inflammatory bowel syndrome, inflammatory bowel disease, bowel resection, Roux-en-Y gastric bypass surgery, celiac disease, Crohn's disease, or colorectal cancer
  • Hypoglycemic episode with blood glucose 70 milligrams per deciliter (mg/dL) within the last month
  • Stage IV-V chronic kidney disease
  • Pregnancy (self-reported)
  • Comorbidity limiting survival to \< 12 months
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Potato starch supplement

    Participants will take the supplement for approximately 4 weeks.

    Dietary Supplement: Potato Starch

Interventions

  • Dietary supplementStarch, potatoStudies of Starch, potatoStarch, potato pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants will consume 10 grams (1/2 a packet) of Bob's Red Mill Potato Starch twice a day for the first 7 days and then increase to 20 grams (full packet) of potato starch for approximately 3 weeks. Potato starch can be mixed into cold food or beverage for consumption. In addition, participants will have evaluations and provide blood and stool samples during the study.

06

What researchers measure

Primary outcomes

  1. Changes in Short Chain Fatty Acid (SCFA) butyrate levels - stool

    Stool will be analyzed.

    Time frame: Baseline, approximately 4 weeks

  2. Changes in Short Chain Fatty Acid (SCFA) butyrate levels - plasma

    Plasma samples will be analyzed.

    Time frame: Baseline, approximately 4 weeks

  3. Changes in propionate levels - stool

    Stool will be analyzed.

    Time frame: Baseline, approximately 4 weeks

  4. Changes in propionate levels- plasma

    Plasma samples will be analyzed.

    Time frame: Baseline, approximately 4 weeks

  5. Changes in acetate levels- stool

    Stool will be analyzed.

    Time frame: Baseline, approximately 4 weeks

  6. Changes in acetate levels- plasma

    Plasma samples will be analyzed.

    Time frame: Baseline, approximately 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jun 2026, 26 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 26 months is above that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2024
First posted
Mar 29, 2024
StartActual
Apr 1, 2024
Primary completionEst.
Jun 2026
CompletionEst.
Dec 2026
Last update
Jul 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06337812
Responsible party
Scott L. Hummel (Associate Professor, University of Michigan) — Principal investigator
First posted
Mar 29, 2024
Start date
Apr 1, 2024
Primary completion
Jun 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 24, 2025

Study contacts

Hayley Billingsley, PhD
Contact
hbilings@med.umich.edu
734-726-0308
Scott Hummel, MD, MS
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Starch, potato

Start the discussion